Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101
PremiumPress ReleasesBright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101
1y ago
Bright Minds Biosciences completes three-part Phase 1 study of BMB-101
PremiumThe Fly
Bright Minds Biosciences completes three-part Phase 1 study of BMB-101
1y ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1y ago
Bright Minds Biosciences wins favorable written opinion from ISA on BMB-202
PremiumThe FlyBright Minds Biosciences wins favorable written opinion from ISA on BMB-202
1y ago
Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research
PremiumPress Releases
Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research
1y ago
Bright Minds provides clinical program updates, anticipated milestones
PremiumThe Fly
Bright Minds provides clinical program updates, anticipated milestones
1y ago
Bright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
PremiumPress ReleasesBright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
2y ago
Bright Minds Biosciences receives Nasdaq bid price notification
PremiumThe Fly
Bright Minds Biosciences receives Nasdaq bid price notification
2y ago
Bright Minds Biosciences Announces Resignation of Board Member
PremiumPress Releases
Bright Minds Biosciences Announces Resignation of Board Member
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100